Skip to content
Close
Customers
Biopharma
MedTech
Payers & Providers
Government
Products
Software Overview
Discover
Substantiate
Data Powered Offerings
Generate
Services
Regulatory & Scientific Services
Data Services
Company
About Us
Regulatory Partnerships
Leadership
Careers
Resources
News
Evidence Hub
Events
CARE Initiative
SEARCH
Let's Talk
Customers
Biopharma
MedTech
Payers & Providers
Government
Products
Software Overview
Discover
Substantiate
Data Powered Offerings
Generate
Services
Regulatory & Scientific Services
Data Services
Company
About Us
Regulatory Partnerships
Leadership
Careers
Resources
News
Evidence Hub
Events
CARE Initiative
Let's Talk
Quick results for "{search_term}"
Admin
May 1, 2021
< 1 min read
Evaluating the Utility of Synthetic COVID-19 Case Data
Previous
Next
A detailed case study demonstrating the high utility and low privacy risks of synthetic data generation for the Ontario COVID-19 case dataset.
Get the report
Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More
Admin
RELATED ARTICLES
